INSIGHTS ON DRUG DEVELOPMENT
-
Small Molecule Orphan Drugs: Status Quo, Challenges, And Perspectives
By establishing robust manufacturing processes and scalable production strategies from the outset, developers can help de-risk orphan drug production, improve efficiency, and position their programs for greater long-term success.
-
Rethinking Design, Cost, And Scalability In Biomanufacturing
Life science teams increasingly need tools that scale, simplify workflows, and reduce operational costs. Examine how emerging instrumentation focuses on usability, performance, and manufacturability.
-
Easy Automation For Cell-Based Assays
Automated GPCR screening is now faster and more scalable with integrated cell-based assay solutions. Discover how combining high-throughput platforms with flexible assay kits can streamline workflows.
-
Formulation Strategies For Enabling "Undevelopable" Compounds
KinetiSol enhances bioavailability of poorly soluble drugs like Vemurafenib by producing dense amorphous dispersions, outperforming traditional MBP methods in pharmacokinetics and dissolution.
-
Expanding Translational Research Concepts With Genedata Profiler11/26/2024
The biopharma industry leverages Genedata Profiler to integrate, curate, and analyze diverse R&D data, enabling collaborative, compliant, and AI-driven translational research to optimize drug development.
-
Enhancing Throughput And Reproducibility In Proteomic Analysis8/27/2025
Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.
-
In Vitro Drug Screening On Cancer Cells10/29/2025
Explore a high-throughput assay combining stain-free imaging and multiplexed viability/toxicity measurements to evaluate drug effects on cancer cells, ideal for labs optimizing cell-based screening.
-
Simplify Cell Line Development10/1/2025
Explore a streamlined method for isolating viable single cells using microfluidic dispensing and whole-well imaging that is designed to improve clonality, cell health, and reproducibility.
-
Dosage Form Scale-Up: Balancing Speed And Efficiency In Later-Stage Development9/22/2026
Reduce development risk and improve readiness for larger trials with strategies that align formulation, manufacturing, and commercialization goals.
DRUG DEVELOPMENT SOLUTIONS
-
Our solutions have been specified in the testing process for the top two GLP-1 manufacturers
-
A60 F Stereo Microscope
Optimize your productivity and production quality
The intuitive A60 F and A60 S stereo microscopes fulfill what you need – high sample throughput, optimum visibility of product details and components, and easy processing of subassemblies.
-
See 80% more of your sample with a 46 mm object field
-
Comfortable access your sample due to the 122 mm working distance
-
Easy handling, less refocusing and time saving with up to 13.6 mm depth of field and Leica FusionOptics technology
-
Enables large surface overview and detailed observation with a magnification range from 5x to 30x
-
-
One MS Software for All Your Mass Spectral Data Analysis and Management
ACD/MS Workbook Suite is an all-in-one package for MS data handling.
- Process MS, LC/MS, and GC/MS data acquired with instruments from any major vendor
- Auto-annotate peaks and associate them with compound structures
- Identify unknowns by deconvoluting spectra and searching databases for spectral matches
- Create easily shareable and searchable spectral databases
-
Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to inadequate insulin production or impaired insulin utilization, commonly known as insulin resistance.
-
Explore a range of devices for free fraction analyses and determination of plasma protein binding that make sample preparation easier and faster, with complete phospholipid removal and proven reproducibility.